Geron (GERN) EBITDA Margin (2010 - 2026)
Geron's EBITDA Margin was -21.50% in Q2 2026, up 3.63 percentage points from -25.14% a year earlier but down 22.07 percentage points from the prior quarter.
Powered by 
Analysis
Geron (GERN) EBITDA Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Geron's EBITDA Margin was -21.03% through Jun 30, 2026, up 22.49 percentage points year-over-year; for FY2025, it came in at -30.53%, up 163.15 percentage points from FY2024.
- EBITDA Margin shows a five-year change of +30307.42 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -193.68% in FY2024 (+81452.73 pp), -81646.41% in FY2023 (-58448.09 pp), -23198.32% in FY2022 (-15030.05 pp) and -8168.27% in FY2021 (+22169.67 pp).
- Quarterly EBITDA Margin has moved between -235543.48% (Q4 2023) and 0.56% (Q1 2026) over five years.
- Compared with a year earlier, EBITDA Margin has increased for ten straight quarters, with an average year-over-year change of +36336.24 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q4 2024 (a gain of 235510.28 percentage points); the worst was Q4 2023 (a drop of 194892.02 percentage points).
- Per Business Quant data, GERN's EBITDA Margin in the three quarters before Q2 2026 was 0.56% (Q1 2026), -29.17% (Q4 2025) and -29.13% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 39.16% |
| 10 | Geron | 814.10 Mn | -537.60 Mn | - | -20.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.98% |
| Mar 31, 2026 | 1.12% |
| Dec 31, 2025 | -28.85% |
| Sep 30, 2025 | -28.56% |
| Jun 30, 2025 | -24.60% |
| Mar 31, 2025 | -41.21% |
| Dec 31, 2024 | -41.54% |
| Sep 30, 2024 | -98.27% |
| Jun 30, 2024 | -7,752.95% |
| Mar 31, 2024 | -18,164.80% |
| Dec 31, 2023 | -234,039.13% |
| Sep 30, 2023 | -28,810.37% |
| Jun 30, 2023 | -177,879.31% |
| Mar 31, 2023 | -189,290.48% |
| Dec 31, 2022 | -40,433.98% |
| Sep 30, 2022 | -13,289.56% |
| Jun 30, 2022 | -37,738.36% |
| Mar 31, 2022 | -22,982.93% |
| Dec 31, 2021 | -2,947.60% |
| Sep 30, 2021 | -23,273.39% |
API Access
Geron EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=GERN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "GERN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=GERN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();